Industry: Chemical & Material
Published Date: 2024-08-24
Pages: 104 Pages
Report ld: 3296834
Request Sample
Customized Report
Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.
The global Myostatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Myostatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Myostatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Myostatin include Bio-Techne, Prospec, NeoScientific, FUJIFILM Irvine Scientific, R&D Systems, Beta Lifescience, ACROBiosystems, Biohaven, RayBiotech, Sino Biological, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Myostatin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Myostatin.
The Myostatin market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Myostatin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Myostatin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Myostatin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Myostatin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Myostatin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Myostatin Market Overview
1.1 Product Definition
1.2 Myostatin by Type
1.2.1 Global Myostatin Market Value Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Active
1.2.3 Inactive
1.3 Myostatin by Application
1.3.1 Global Myostatin Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Gene Therapy
1.3.3 Basic Scientific Research
1.3.4 Treating Muscular Dystrophy
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Myostatin Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Myostatin Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Myostatin Production Estimates and Forecasts (2019-2030)
1.4.4 Global Myostatin Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Myostatin Production Market Share by Manufacturers (2019-2024)
2.2 Global Myostatin Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Myostatin, Industry Ranking, 2022 VS 2023
2.4 Global Myostatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Myostatin Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Myostatin, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Myostatin, Product Offered and Application
2.8 Global Key Manufacturers of Myostatin, Date of Enter into This Industry
2.9 Myostatin Market Competitive Situation and Trends
2.9.1 Myostatin Market Concentration Rate
2.9.2 Global 5 and 10 Largest Myostatin Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Myostatin Production by Region
3.1 Global Myostatin Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Myostatin Production Value by Region (2019-2030)
3.2.1 Global Myostatin Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Myostatin by Region (2025-2030)
3.3 Global Myostatin Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Myostatin Production by Region (2019-2030)
3.4.1 Global Myostatin Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Myostatin by Region (2025-2030)
3.5 Global Myostatin Market Price Analysis by Region (2019-2024)
3.6 Global Myostatin Production and Value, Year-over-Year Growth
3.6.1 North America Myostatin Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Myostatin Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Myostatin Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Myostatin Production Value Estimates and Forecasts (2019-2030)
4 Myostatin Consumption by Region
4.1 Global Myostatin Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Myostatin Consumption by Region (2019-2030)
4.2.1 Global Myostatin Consumption by Region (2019-2030)
4.2.2 Global Myostatin Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Myostatin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Myostatin Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Myostatin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Myostatin Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Myostatin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Myostatin Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Myostatin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Myostatin Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Myostatin Production by Type (2019-2030)
5.1.1 Global Myostatin Production by Type (2019-2024)
5.1.2 Global Myostatin Production by Type (2025-2030)
5.1.3 Global Myostatin Production Market Share by Type (2019-2030)
5.2 Global Myostatin Production Value by Type (2019-2030)
5.2.1 Global Myostatin Production Value by Type (2019-2024)
5.2.2 Global Myostatin Production Value by Type (2025-2030)
5.2.3 Global Myostatin Production Value Market Share by Type (2019-2030)
5.3 Global Myostatin Price by Type (2019-2030)
6 Segment by Application
6.1 Global Myostatin Production by Application (2019-2030)
6.1.1 Global Myostatin Production by Application (2019-2024)
6.1.2 Global Myostatin Production by Application (2025-2030)
6.1.3 Global Myostatin Production Market Share by Application (2019-2030)
6.2 Global Myostatin Production Value by Application (2019-2030)
6.2.1 Global Myostatin Production Value by Application (2019-2024)
6.2.2 Global Myostatin Production Value by Application (2025-2030)
6.2.3 Global Myostatin Production Value Market Share by Application (2019-2030)
6.3 Global Myostatin Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Bio-Techne
7.1.1 Bio-Techne Myostatin Company Information
7.1.2 Bio-Techne Myostatin Product Portfolio
7.1.3 Bio-Techne Myostatin Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Bio-Techne Main Business and Markets Served
7.1.5 Bio-Techne Recent Developments/Updates
7.2 Prospec
7.2.1 Prospec Myostatin Company Information
7.2.2 Prospec Myostatin Product Portfolio
7.2.3 Prospec Myostatin Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Prospec Main Business and Markets Served
7.2.5 Prospec Recent Developments/Updates
7.3 NeoScientific
7.3.1 NeoScientific Myostatin Company Information
7.3.2 NeoScientific Myostatin Product Portfolio
7.3.3 NeoScientific Myostatin Production, Value, Price and Gross Margin (2019-2024)
7.3.4 NeoScientific Main Business and Markets Served
7.3.5 NeoScientific Recent Developments/Updates
7.4 FUJIFILM Irvine Scientific
7.4.1 FUJIFILM Irvine Scientific Myostatin Company Information
7.4.2 FUJIFILM Irvine Scientific Myostatin Product Portfolio
7.4.3 FUJIFILM Irvine Scientific Myostatin Production, Value, Price and Gross Margin (2019-2024)
7.4.4 FUJIFILM Irvine Scientific Main Business and Markets Served
7.4.5 FUJIFILM Irvine Scientific Recent Developments/Updates
7.5 R&D Systems
7.5.1 R&D Systems Myostatin Company Information
7.5.2 R&D Systems Myostatin Product Portfolio
7.5.3 R&D Systems Myostatin Production, Value, Price and Gross Margin (2019-2024)
7.5.4 R&D Systems Main Business and Markets Served
7.5.5 R&D Systems Recent Developments/Updates
7.6 Beta Lifescience
7.6.1 Beta Lifescience Myostatin Company Information
7.6.2 Beta Lifescience Myostatin Product Portfolio
7.6.3 Beta Lifescience Myostatin Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Beta Lifescience Main Business and Markets Served
7.6.5 Beta Lifescience Recent Developments/Updates
7.7 ACROBiosystems
7.7.1 ACROBiosystems Myostatin Company Information
7.7.2 ACROBiosystems Myostatin Product Portfolio
7.7.3 ACROBiosystems Myostatin Production, Value, Price and Gross Margin (2019-2024)
7.7.4 ACROBiosystems Main Business and Markets Served
7.7.5 ACROBiosystems Recent Developments/Updates
7.8 Biohaven
7.8.1 Biohaven Myostatin Company Information
7.8.2 Biohaven Myostatin Product Portfolio
7.8.3 Biohaven Myostatin Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Biohaven Main Business and Markets Served
7.8.5 Biohaven Recent Developments/Updates
7.9 RayBiotech
7.9.1 RayBiotech Myostatin Company Information
7.9.2 RayBiotech Myostatin Product Portfolio
7.9.3 RayBiotech Myostatin Production, Value, Price and Gross Margin (2019-2024)
7.9.4 RayBiotech Main Business and Markets Served
7.9.5 RayBiotech Recent Developments/Updates
7.10 Sino Biological
7.10.1 Sino Biological Myostatin Company Information
7.10.2 Sino Biological Myostatin Product Portfolio
7.10.3 Sino Biological Myostatin Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Sino Biological Main Business and Markets Served
7.10.5 Sino Biological Recent Developments/Updates
7.11 BioVendor
7.11.1 BioVendor Myostatin Company Information
7.11.2 BioVendor Myostatin Product Portfolio
7.11.3 BioVendor Myostatin Production, Value, Price and Gross Margin (2019-2024)
7.11.4 BioVendor Main Business and Markets Served
7.11.5 BioVendor Recent Developments/Updates
7.12 Cell Guidance Systems
7.12.1 Cell Guidance Systems Myostatin Company Information
7.12.2 Cell Guidance Systems Myostatin Product Portfolio
7.12.3 Cell Guidance Systems Myostatin Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Cell Guidance Systems Main Business and Markets Served
7.12.5 Cell Guidance Systems Recent Developments/Updates
7.13 MerckMillipore
7.13.1 MerckMillipore Myostatin Company Information
7.13.2 MerckMillipore Myostatin Product Portfolio
7.13.3 MerckMillipore Myostatin Production, Value, Price and Gross Margin (2019-2024)
7.13.4 MerckMillipore Main Business and Markets Served
7.13.5 MerckMillipore Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Myostatin Industry Chain Analysis
8.2 Myostatin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Myostatin Production Mode & Process
8.4 Myostatin Sales and Marketing
8.4.1 Myostatin Sales Channels
8.4.2 Myostatin Distributors
8.5 Myostatin Customers
9 Myostatin Market Dynamics
9.1 Myostatin Industry Trends
9.2 Myostatin Market Drivers
9.3 Myostatin Market Challenges
9.4 Myostatin Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Myostatin market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 163
USD 4900.00
(Single User License)
The global Myostatin market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 96
USD 4250.00
(Single User License)
The global market for Myostatin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 126
USD 3950.00
(Single User License)
The global Myostatin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 145
USD 2900.00
(Single User License)
The global Myostatin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 169
USD 4900.00
(Single User License)
The global Myostatin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 97
USD 4250.00
(Single User License)
The global market for Myostatin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 104
USD 2900.00
(Single User License)
The global market for Myostatin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 116
USD 3950.00
(Single User License)
Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.
Published Date: 2024-08-24
Pages: 124
USD 4350.00
(Single User License)
Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.
Published Date: 2024-08-24
Pages: 166
USD 4900.00
(Single User License)
The global Myostatin market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 163
The global Myostatin market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 96
The global market for Myostatin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 126
The global Myostatin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 145
The global Myostatin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 169
The global Myostatin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 97
The global market for Myostatin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 104
The global market for Myostatin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 116
Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.
Published: 2024-08-24
Pages: 124
Myostatin, also known as growth differentiation factor-8 (GDF-8), plays a key role in regulating muscle growth in animals, including humans. It is a member of the transforming growth factor-beta (TGF-β) superfamily, which is involved in regulating various cellular processes such as cell growth, proliferation, differentiation, and apoptosis.Myostatin is a protein that negatively regulates muscle growth by inhibiting muscle cell proliferation and differentiation. It is crucial for maintaining balanced muscle development and is encoded by the MSTN gene. Myostatin's activity has implications for muscle-wasting diseases and muscle hypertrophy, making it a target for therapeutic research.
Published: 2024-08-24
Pages: 166
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now